Aniara | Shaping the Future with Innovative Solutions
 
 Search
 

Learning Center

Hemostasis Happenings


Wednesday, March 3, 2010

HEMOSTASIS HAPPENINGS: MARCH 2010

MARCH IS DVT AWARENESS MONTH!

http://www.clotcare.com/clotcare/deepveinthrombosisdvtcoalition.aspx
Blhttp://www.stoptheclot.org/contact.htmood Clot Awareness Month
Teleconferences & Live Webcasts

Education & Support
ttp://www.stoptheclot.org/contact.htmhttp://www.stoptheclot.org/contact.htm
1.0 NATT Announces Two Events for March - Blhttp://www.stoptheclot.org/contact.htmood Clot Awareness Month
The National Alliance for Thrombosis and Thrombophilia (NATT) teams with the Association of Black Women Attorneys (ABWA) on a 5K walk to raise awareness about blood clots, particularly within the African American population. ABWA's Community Service Committee chose to sponsor this 5K walk on Saturday, March 20, 2010 because March is Blood Clot Awareness Month. The walk begins at 11:00 AM, in Prospect Park Brooklyn, although "Check-In" begins at 10:00 AM at the Bartel Pritchard Square entrance at Prospect Park West and 15th Street in Brooklyn.
Georgia's Boutique in Soho, NY, on Thursday, March 25, 2010 from 6:00-9:00 PM is hosting a reception to celebrate the success of the walk and to continue the effort to fundraise for NATT and alert attendees about the risk of blood clots. We are honored that Dr. Sharif Ellozy, a vascular surgeon from Mount Sinai Medical Center, is scheduled to speak at this event.







eCase-Oriented Symposium on Bleeding and Thrombosis
March 18-19, 2010
QUEST LABORATORIES

Hyatt Regency - Reston, VA (near Washington, DC)
www.nicholsinstitute.com/coagulation

Thursday MARCH 18 7:00 - 8:00 REGISTRATION & CONTINENTAL BREAKFAST
7:55 - 8:00 WELCOME & INTRODUCTIONS
8:00 - 9:00 Michael Mosesson, M.D. DYSFIBRINOGENEMIA & THROMBOPHILIA
9:00 - 10:00 John Eikelboom, MBBS, MSc ASPIRIN RESISTANCE
10:00 - 10:30 NETWORKING BREAK IN EXHIBIT HALL
10:30 - 11:30 Marilyn Manco-Johnson, M.D. PEDIATRIC HEMOSTASIS
11:30 - 12:30 Charles Eby, M.D. WARFARIN PHARMACOGENETICS
12:30 - 1:45 LUNCH IN EXHIBIT HALL
1:45 - 2:45 Alexander Duncan, M.D. WOMEN'S HEALTH & HEMOSTASIS
2:45 - 3:45 Jeffrey Dlott, M.D. MIMICKERS OF LUPUS ANTICOAGULANTS
3:45 - 4:00 NETWORKING BREAK IN EXHIBIT HALL
4:00 - 5:00 NEW TECHNOLOGY FORUM
5:00 - 6:30 COCKTAIL RECEPTION IN EXHIBIT HALL
Friday MARCH 19 7:00 - 8:00 REGISTRATION & CONTINENTAL BREAKFAST
8:00 - 9:00 Robert Handin, M.D. ACQUIRED VON WILLEBRAND DISEASE
9:00 - 10:00 Mervyn Sahud, M.D. THE UTILITY OF CHROMOGENIC ASSAYS FOR SPECIALTY COAGULATION TESTING
10:00 - 10:30 NETWORKING BREAK IN EXHIBIT HALL
10:30 - 11:30 Catherine Hayward, M.D., Ph.D. PLATELET ABNORMALITIES
11:30 - 12:30 John Olson, M.D., Ph.D. COAGULATION CASE STUDY POTPOURRI
12:30 MEETING ADJOURNED AND BOX LUNCHES ARE AVAILABLE



FLORIDA SOCIETY OF CLINICAL LABORATORY SCIENCE Spring 2010 Symposium
Hilton Hotel in Altamonte Springs, Florida.










Friday, March 5, 2010 continued Time Session# Topic CE Credits
(CEUs)
10:30 - 11:30 am 15 How Good is Your INR? New Concept in PT/INR Standardization
Diane Shafer, MT(ASCP), Hemostasis Marketing Manger, Siemens Healthcare Diagnostics
Despite the widespread use and acceptance of the INR system for reporting prothrombin times, interlaboratory variability in PT/INR reporting persists. In this session, the limitations of the INR system will be discussed as well as the concept of calibrated plasmas for verification and calibration of PT/INR systems. 1.0 contact hour
Hematology







AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
TELECONFERENCE
Tuesday: MARCH 30, 2009
Diagnosing Factor Deficiencies in the Coagulation Laboratory:
A Case Study Approach ; Donna D. Castellone, MS, MT(ASCP)SH
1pm CST.

Donna Castellone

Bookmark and Share

 

About the Author

Donna Castellone,  MS, MT(ASCP)SH

Donna Castellone,
MS, MT(ASCP)SH

View Complete Profile


Links


Previous Posts


Archives

RSS Feed

 
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
Aniara